Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.
Csermely A, Mantovani A, Morieri ML, Palmisano L, Masulli M, Cossu E, Baroni MG, Bonomo K, Cimini FA, Cavallo G, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Pollis RM, Aldigeri R, Cas AD, de Kreutzenberg SV, Targher G. Csermely A, et al. Among authors: mignogna c. Diabetes Metab. 2023 Nov;49(6):101477. doi: 10.1016/j.diabet.2023.101477. Epub 2023 Sep 12. Diabetes Metab. 2023. PMID: 37708990
Adult-onset autoimmune diabetes in 2020: An update.
Maddaloni E, Moretti C, Mignogna C, Buzzetti R. Maddaloni E, et al. Among authors: mignogna c. Maturitas. 2020 Jul;137:37-44. doi: 10.1016/j.maturitas.2020.04.014. Epub 2020 Apr 30. Maturitas. 2020. PMID: 32498935 Review.
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I).
Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Coraggio L, Sterpetti S, Pascarella G, Mezzaroma I, Lichtner M, Pozzilli P, Agrò FE, Rocco M, Pugliese F, Mastroianni CM, Buzzetti R; CoViDiab Study group. Maddaloni E, et al. Among authors: mignogna c. Diabetes Res Clin Pract. 2020 Nov;169:108454. doi: 10.1016/j.diabres.2020.108454. Epub 2020 Sep 21. Diabetes Res Clin Pract. 2020. PMID: 32971157 Free PMC article.
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study.
D'Onofrio L, Mignogna C, Carlone A, Bellizzi E, Di Guida M, Moretti C, Zampetti S, Leto G, Maddaloni E, Buzzetti R. D'Onofrio L, et al. Among authors: mignogna c. Diabetes Res Clin Pract. 2021 Mar;173:108681. doi: 10.1016/j.diabres.2021.108681. Epub 2021 Jan 28. Diabetes Res Clin Pract. 2021. PMID: 33516784
Development of a clinical risk score to predict death in patients with COVID-19.
Alhamar G, Maddaloni E, Al Shukry A, Al-Sabah S, Al-Haddad M, Al-Youha S, Jamal M, Almazeedi S, Al-Shammari AA, Abu-Farha M, Abubaker J, Alattar AT, AlOzairi E, Alessandri F, D'Onofrio L, Leto G, Mastroianni CM, Mignogna C, Pascarella G, Pugliese F, Ali H, Al Mulla F, Buzzetti R, Pozzilli P. Alhamar G, et al. Among authors: mignogna c. Diabetes Metab Res Rev. 2022 Jul;38(5):e3526. doi: 10.1002/dmrr.3526. Epub 2022 Mar 22. Diabetes Metab Res Rev. 2022. PMID: 35262260 Free PMC article.
Diastolic Pressure and ACR Are Modifiable Risk Factors of Arterial Stiffness in T2DM Without Cardiovascular Disease.
Leto G, Tartaglione L, Rotondi S, Pasquali M, Maddaloni E, Mignogna C, D'Onofrio L, Zampetti S, Carlone A, Muci ML, Mastroluca D, Fassino V, Buzzetti R, Mazzaferro S. Leto G, et al. Among authors: mignogna c. J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3857-e3865. doi: 10.1210/clinem/dgac291. J Clin Endocrinol Metab. 2022. PMID: 35595474
131 results